APLN and type 2 diabetes mellitus: In this connection, the apelin-APJ system appears to be a useful surrogate target for management of HF in T2DM; knowledge of underlying molecular mechanisms and biological functions of apelin and its receptor APJ in the pathophysiology of both diseases may stimulate new approaches to management [50].